Aculys Pharma Appoints Hidemasa Tanigaki as Chief Executive Officer and Representative Director
Position
Chief Executive Officer
Company
Aculys Pharma
TokyoBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharmaDescription
Aculys Pharma, Inc. announces the appointment of Hidemasa Tanigaki as Chief Executive Officer and Representative Director, effective March 29th. Hidemasa Tanigaki brings over 30 years of experience in the pharmaceutical sector, having held key positions in Takeda Pharmaceutical Company and Nihon Pharmaceutical Co., Ltd.
Quick answer
Aculys Pharma Appoints Hidemasa Tanigaki as Chief Executive Officer and Representative Director (April 1, 2024). Aculys Pharma is based in Tokyo, Tokyo, Japan.
- Who is the new Chief Executive Officer at Aculys Pharma?
- Aculys Pharma named Hidemasa Tanigaki Chief Executive Officer, announced April 1, 2024.
- What did Aculys Pharma announce on April 1, 2024?
- Aculys Pharma, Inc. announces the appointment of Hidemasa Tanigaki as Chief Executive Officer and Representative Director, effective March 29th.
- What does Aculys Pharma do?
- Aculys Pharma, Inc. is a clinical-stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions.
- Where is Aculys Pharma based?
- Aculys Pharma is based in Tokyo, Tokyo, Japan.
- Which similar companies made leadership changes around the same time?
- Acadia Pharmaceuticals (April 2, 2024), Fulcrum Therapeutics (March 18, 2024), Oragenics (March 18, 2024) and Madrigal Pharmaceuticals (March 11, 2024) also announced leadership changes within 45 days of Aculys Pharma.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Acadia Pharmaceuticals Appoints Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development (April 2, 2024)
- Fulcrum Appoints Patrick Horn, M.D., Ph.D., as Chief Medical Officer (March 18, 2024)
- Oragenics Appoints Dr. James Kelly as Chief Medical Officer (March 18, 2024)
- Madrigal Pharmaceuticals Appoints Mardi C. Dier as Senior Vice President and Chief Financial Officer (March 11, 2024)
- MBrace Appoints Steve Alley, Ph.D., as Chief Scientific Officer (March 5, 2024)
- Apollomics Appoints Matthew Plunkett as Chief Financial Officer (March 4, 2024)
Who to call at Aculys Pharma, and when
A new leader at Aculys Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Aculys Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aculys Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aculys Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aculys Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aculys Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.